Resources
Proposed Transaction Provides Significant, Immediate, and Certain Value to Shareholders Proposed Transaction Result of Comprehensive, Multi-Month Strategic Review Process Led....
100% of G2 reviewers plan to renew — Kneat leads pharma software for five quarters running.
Kneat Shareholders to Receive C$6.50 Per Share in Cash, a 40% Premium to Kneat’s Unaffected Share Price Transaction to accelerate....
LIMERICK, Ireland, May 27, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”), a....
Pfizer honored at VALIDATE 2026 for global digital validation innovation.
LIMERICK, Ireland, May 13, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader....
LIMERICK, Ireland, May 11, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader....
Largest respondent base in the five-year history of the annual study links digital maturity with AI readiness LIMERICK, Ireland, April....
LIMERICK, Ireland, April 28, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation....